Home 
CUSTOMERS Bratislava Medical Journal 2020 Bratislava Medical Journal Vol.121, No.11, p.817–821,2020
CUSTOMERS Bratislava Medical Journal 2020 Bratislava Medical Journal Vol.121, No.11, p.817–821,2020
Journal info
|
||||
Select Journal
Journals
Acta Virologica Bratislava Medical Journal Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.121, No.11, p.817–821,2020 |
||
| Title: Ventricular repolarization indexes in patients treated with hydroxychloroquine – azithromycin combination for COVID-19 | ||
| Author: S. Gunay, S. Caliskan, D. Sigirli, E. Sahin | ||
| Abstract: BACKGROUND: Combination of hydroxychloroquine and azithromycin for the treatment of coronavirus disease 2019 (COVID-19) carries increased risk of corrected QT (QTc) prolongation and cardiac arrhythmias. OBJECTIVE: To characterize the ventricular repolarization indexes which are associated with malignant ventricular arrhythmias in patients treated with hydroxychloroquine and concomitant azithromycin for COVID-19. METHOD: A total of 81 patients who had hydroxychloroquine and azithromycin combination therapy because of possible or reverse-transcription polymertase chain reaction (RT-PCR) confirmed diagnosis of COVID-19 were included in the study. Baseline and control electrocardiograms (before and after treatment) were analyzed retrospectively. Tp-e interval, Tp-e/QT and Tp-e/QTc ratios, which are ventricular repolarization indexes, were calculated. RESULTS: While there was no significant increase in QTc interval in patients receiving combination therapy, there was a significant increase in ventricular repolarization indexes. CONCLUSION: The increase in ventricular replarization indexes is associated with the risk of arrhythmia. In patients using QTc prolonging medication for COVID-19 treatment, QTc monitoring alone may not be sufficient to follow-up for arrhythmia. Even if there is no prolongation in QTc, an increase in ventricular repolarization indexes may be seen (Tab. 5, Ref. 37). |
||
| Keywords: hydroxychloroquine, azithromycin, QTc prolongation, Tp-e, repolarization, arrhythmia | ||
| Published online: 09-Nov-2020 | ||
| Year: 2020, Volume: 121, Issue: 11 | Page From: 817, Page To: 821 | |
| doi:10.4149/BLL_2020_134 |
||
|
|
 download file |
|